KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 20 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,154,000 | +160.1% | 5,000,000 | +150.0% | 0.15% | +163.2% |
| Q4 2021 | $1,597,000 | +6.9% | 2,000,000 | 0.0% | 0.06% | -10.9% |
| Q3 2021 | $1,494,000 | -25.0% | 2,000,000 | 0.0% | 0.06% | -22.0% |
| Q2 2021 | $1,991,000 | -47.3% | 2,000,000 | -33.3% | 0.08% | -43.4% |
| Q4 2020 | $3,781,000 | +4.9% | 3,000,000 | 0.0% | 0.14% | -14.7% |
| Q3 2020 | $3,603,000 | +28.2% | 3,000,000 | +50.0% | 0.17% | +6.9% |
| Q2 2020 | $2,811,000 | -35.2% | 2,000,000 | -33.3% | 0.16% | -53.5% |
| Q1 2020 | $4,337,000 | +0.4% | 3,000,000 | 0.0% | 0.34% | +43.1% |
| Q4 2019 | $4,318,000 | – | 3,000,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
| Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
| DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
| BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
| MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
| JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |